Brisbane Clinical Trials
The Meal Impact Study
The study drug is exploring a potential new treatment for inflammation and autoimmune diseases.
2 x 5 nights
9 follow-ups, 1 phone call visits
The investigational treatment is being developed to potentially help manage immune-mediated diseases by inhibiting a specific enzyme, which reduces the activity of certain immune cells. This study builds on previous data and aims to explore higher doses and the effect of food on the treatment's absorption to optimize its safety and effectiveness
As a participant, you’ll receive the study medication and undergo assessments to monitor how your body responds. Your involvement will provide essential data that can help guide future research.
Call us on 1300 512 417 to discuss your eligibility today!
Eligibility
Biological Sex Males or Females of non-child-bearing potential
Age 18-60 years old
Weight ≥50kg
BMI ≥18.0 - ≤32.0kg/m²
Medical History No significant medical history
Smoking History Non-smokers or no smoking 1 month prior to admission